Search results
Results from the WOW.Com Content Network
The liquid biopsy is considered a minimally invasive procedure because, unlike other methods of tissue biopsy, such as the solid traditional tissue biopsy, it only necessitates a small amount of blood sample. Liquid biopsy testing has grown in acceptance in clinical settings due to its many advantages, which have assisted in the market's expansion.
Guardant Health said the test would be the "first and only comprehensive biopsy-free cancer test available". [7] In 2016, the company announced clinical trial results demonstrating the test "detected disease-associated genetic mutations that were also present in 94% to 100% of the solid tissues extracted from the study's subjects". [8]
Their liquid biopsy (also called multi-cancer early detection test [4]) was launched in June 2021 and is called the Galleri test. Promoted as groundbreaking, the test performed poorly in testing and Grail has subsequently faced discontent and legal action from investors claiming they have been misled about the test's potential.
The NIFTY 50 index covers 13 sectors of the Indian economy and offers investment managers exposure to the Indian market in one portfolio. As of July 2024, NIFTY 50 gives a weightage of 32.76% to financial services including banking , 13.76% to information technology , 12.12% to oil and gas , 8.46% to consumer goods , and 8.22% to automotive .
In fact, some stocks ... Many U.S. companies are enduring near total shutdowns while the country tries to mitigate the fallout from the COVID-19 outbreak. 8 Most Liquid Stocks to Buy Now
Here are four top-performing liquid stocks, Louisiana-Pacific (LPX), Magnolia Oil & Gas Corporation (MGY), Buckle (BKE) and SeaWorld Entertainment (SEAS), which investors can add to their ...
Some of the popular exchange-traded funds (ETF) traded on the National Stock Exchange of India of 25th April 2024 are [1]. Nippon India Nippon India ETF Nifty 1D Rate Liquid BeES (NSE: LIQUIDBEES) (Formerly called Reliance ETF Liquid BeES)
India's revenue from pharmaceutical exports was $25.3 billion in the 2022-2023 financial year. [7] In terms of the global market, India currently holds an accountable share and is known as the pharmacy of the world. [9] The country is the largest global supplier of generic medicine. [10] India produces more than 50% the world's vaccines. [11]